इसराइल - हिब्रू - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

इसराइल - हिब्रू - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.5 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: carcinoid tumours with features of the carcinoid syndrome. vipomas . glucagonomas . gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy . insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy . grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

इसराइल - हिब्रू - Ministry of Health

novartis israel ltd - ciclosporin - תמיסה לאינפוזיה - ciclosporin 50 mg/ml - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation.

बेलारूस - रूसी - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

meril life sciences pvt. ltd., ИНДИЯ -

बेलारूस - रूसी - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

cutting edge sas, ФРАНЦИЯ -

बेलारूस - रूसी - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

cutting edge sas, ФРАНЦИЯ -

ट्यूनीशिया - फ़्रेंच - Ministère de la Santé, Direction de l'inspection Pharmaceutique

unimed - furosemide - solution injectable - 20 mg/2ml - systeme cardiovasculaire - diuretiques - -hypertension accompagnée d'une atteinte viscérale menaçant le pronostic vital à très court terme (urgence hypertensive), notamment lors de: *encéphalopathie hyprtensive *décompensation ventriculaire gauche avec oedème pulmonaire - urgences cardiologiques: oedème aigu du poumon, asystolie. - rétention sodée sévère d'origine cardiaque, rénale, cirrhotique. - radiologie du bas appareil urinaire et test de lavage "wash out" au furoxem - peut etre utilisé en réanimation pédiatrique

ट्यूनीशिया - फ़्रेंच - Ministère de la Santé, Direction de l'inspection Pharmaceutique

infomed pharma - sonnerie - solution injectable pour perfusion - sang et organes hematopoietiques - substituts du sang et solutions de perfusion - - déshydratation à prédominance extracellulaire quelle qu'en soit la cause (vomissement, diarrhée, fistules..); - hypovolémie qu'elle qu'en soit la cause; - chocs hémorragiques; - brùlures; - hyperkaliémie; - hypercalcémie; - alcalose.

इसराइल - हिब्रू - Ministry of Health

unipharm ltd, israel - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan - valsartan - for the treatment of hypertension for patients in whom combination therapy is appropriate.

इसराइल - हिब्रू - Ministry of Health

unipharm ltd, israel - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan - valsartan - for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.